Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Breast biopsy & localization · Tennessee | Breast biopsy & localization · Florida | |
|---|---|---|
| Surgeons, 2024 | 81 | 245 |
| Medicare fee-for-service cases | 4,468 | 16,085 |
| Growth since 2019 (Medicare FFS) | −4.7%/yr | −0.7%/yr |
| Forecast cases (Medicare FFS) | 4,740 in 2030 | 18,600 in 2030 |
| Forecast growth | +1%/yr to 2030 | +2.5%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 6.8 | 7.7 |
| Medicare Advantage share | 57% | 60% |
| Out of hospital | 31% (+5 pts since 2019) | 39% (−3 pts since 2019) |
| Cases per surgeon | 55 | 66 |
| Top 10 surgeons' share | 31% | 14% |
| Surgeons growing | 7 | 48 |
| New since the base year | 12 | 48 |
| Likely to stop billing it | 18 by 2026 | 38 by 2026 |
| Forecast miss, 1 year (procedure) | 3% | 3% |
| Company payments per surgeon | $2,281 | $4,178 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.